
Dr. Nadia Ghazali
@nnadiagee
Clinical Fellow Medical Oncology.
Proud full time working mum.
Supporting women in medicine.
ID: 43644949
31-05-2009 05:01:49
15,15K Tweet
690 Followers
644 Following

New supplement! 📗 Major advances in the systemic treatment of #NSCLC have been made over the past 20 years. CANCER is pleased to deliver 8 comprehensive reviews on targeted therapies for NSCLC written by leading global experts. acsjournals.onlinelibrary.wiley.com/toc/10970142/2… OncoAlert


🚨 New Perspective on ctDNA in NSCLC: Understanding Acquired Resistance 🧬🩸 📖 NatureRevClinOncol , 2025 🔬 This expert review outlines how circulating tumor DNA (ctDNA) is reshaping the detection of acquired resistance to targeted therapies in metastatic NSCLC. 🔍 Key






📗 From the Targeted Therapies in NSCLC supplement | A review discussing ALK-positive lung cancer, including treatment efficacy, safety profiles, mechanisms of resistance, and promising new treatments in the field. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert Dr. Nadia Ghazali IASLC


Have you started your application to join us this summer as we launch our next crew to the International Space Station? Tell us why you should attend the #Crew11 #NASASocial—Monday, April 28 is your deadline: nasa.gov/social-media/n…










Our review on key advancements in #liquidbiopsy in 2024 is finally out! This work was made possible thanks to the incredible team effort of the International Society of Liquid Biopsy Young Committee. 📰Check it out! ➡️ sciencedirect.com/science/articl…


International Society of Liquid Biopsy Carolina Reduzzi Mohamed A Gouda Cristofanilli CTC Laboratory Eleonora Nicolò Letizia Pontolillo @shurbisinghal @diegodemiguelperez Erick Saldanha, MD Pasquale Pisapia Konstantinos Venetis Ana Ortega Franco Dr. Nadia Ghazali Christian Rolfo Umberto Malapelle M JOSE SERRANO Lab (LB&Cancer Interception group) David Gandara ELO
